Latest Articles
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case - First India
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case First India
Published: June 17, 2026, 1:57 p.m.
Bliss IVF Highlights Fertility Success Through Twin Birth In Advanced Endometriosis Case - outlookbusiness.com
Bliss IVF Highlights Fertility Success Through Twin Birth In Advanced Endometriosis Case outlookbusiness.com
Published: June 17, 2026, 1:44 p.m.
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case - NewsX
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case NewsX
Published: June 17, 2026, 1:06 p.m.
Leerink’s AI Pipeline Focus and Jones AI Day Spotlight Might Change The Case For Investing In Absci (ABSI) - simplywall.st
Leerink’s AI Pipeline Focus and Jones AI Day Spotlight Might Change The Case For Investing In Absci (ABSI) simplywall.st
Published: June 17, 2026, 9:33 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - beQuoted
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat beQuoted
Published: June 17, 2026, 9 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - The Manila Times
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat The Manila Times
Published: June 17, 2026, 8:29 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Yahoo Finance Singapore
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Yahoo Finance Singapore
Published: June 17, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Dagens industri
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Dagens industri
Published: June 17, 2026, 7:01 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Cision News
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Cision News
Published: June 17, 2026, 7 a.m.
Association between urinary heavy metals, phthalates, phytoestrogens, and polycyclic aromatic hydrocarbons and endometriosis: A cross-sectional study from NHANES 1999 to 2016.
Research on the association between urinary heavy metals, phthalates, phytoestrogens (PEs), polycyclic aromatic hydrocarbons (PAHs), and endometriosis (EM) is limited. Data were from the National Health and Nutrition Examination Survey …
Published: June 17, 2026, midnight
Link copied to clipboard!